Paul D Scanlon
Overview
Explore the profile of Paul D Scanlon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yadav H, Hefazi Torghabeh M, Hoskote S, Pennington K, Lim K, Scanlon P, et al.
Curr Res Transl Med
. 2024 Jan;
72(2):103432.
PMID: 38244276
Background: Diffusing capacity (DLCO) measurements are affected by hemoglobin. Two adjustment equations are used: Cotes (recommended by ATS/ERS) and Dinakara (used in the hematopoietic stem cell transplantation comorbidity index [HCT-CI])....
2.
Nemoto M, Koo C, Scanlon P, Ryu J
Mayo Clin Proc
. 2023 Nov;
98(11):1685-1696.
PMID: 37923525
Combined pulmonary fibrosis and emphysema (CPFE) syndrome refers to co-occurrence of two disease processes in the lung that can be difficult to diagnose but is associated with high morbidity and...
3.
Kanj A, Scanlon P, Yadav H, Smith W, Herzog T, Bungum A, et al.
Am J Respir Crit Care Med
. 2023 Jul;
209(1):83-90.
PMID: 37523681
Global Lung Function Initiative (GLI) Global spirometry reference equations were recently derived to offer a "race-neutral" interpretation option. The impact of transitioning from the race-specific GLI-2012 to the GLI Global...
4.
Subat Y, Meyer T, Torgerud K, Lim K, Scanlon P, Niven A
Respir Care
. 2022 May;
67(8):899-905.
PMID: 35610032
Background: Methacholine challenge testing (MCT) is a common bronchoprovocation technique used to assess airway hyper-responsiveness. We previously demonstrated that the addition of a viral filter to the nebulizer exhalation limb...
5.
Kawut S, Krowka M, Forde K, Al-Naamani N, Krok K, Patel M, et al.
Eur Respir J
. 2021 Dec;
60(2).
PMID: 34949701
Background: Hepatopulmonary syndrome affects 10-30% of patients with cirrhosis and portal hypertension. We evaluated the serum angiogenic profile of hepatopulmonary syndrome and assessed the clinical impact of hepatopulmonary syndrome in...
6.
Subat Y, Hainy M, Torgerud K, Sajgalik P, Guntupalli S, Johnson B, et al.
Respir Care
. 2021 Nov;
66(12):1858-1865.
PMID: 34789516
Background: Methacholine bronchoprovocation or challenge testing (MCT) is commonly performed to assess airway hyper-responsiveness in the setting of suspected asthma. Nebulization is an aerosol-generating procedure, but little is known about...
7.
Dransfield M, Voelker H, Bhatt S, Brenner K, Casaburi R, Come C, et al.
N Engl J Med
. 2019 Oct;
381(24):2304-2314.
PMID: 31633896
Background: Observational studies suggest that beta-blockers may reduce the risk of exacerbations and death in patients with moderate or severe chronic obstructive pulmonary disease (COPD), but these findings have not...
8.
Krishnan J, Voelker H, Connett J, Niewoehner D, Albert R, Scanlon P, et al.
Eur Respir J
. 2019 Mar;
53(3).
PMID: 30819817
No abstract available.
9.
Mirza S, Clay R, Koslow M, Scanlon P
Mayo Clin Proc
. 2018 Oct;
93(10):1488-1502.
PMID: 30286833
Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a consensus report published periodically since 2001 by an international panel of health professionals from respiratory medicine, socioeconomics,...
10.
Forde K, Fallon M, Krowka M, Sprys M, Goldberg D, Krok K, et al.
Hepatology
. 2018 Aug;
69(1):270-281.
PMID: 30070715
Screening for hepatopulmonary syndrome (HPS) using pulse oximetry is recommended in liver transplant (LT) candidates because mortality is increased, independently of the severity of the oxygenation defect. LT exception points...